Intermediate Dose Thalidomide (200 mg Daily) has Comparable...

Leukemia and Lymphoma 2003 / 01 Vol. 44; Iss. 7

Intermediate Dose Thalidomide (200 mg Daily) has Comparable Efficacy and Less Toxicity than Higher Doses in Relapsed Multiple Myeloma

Wechalekar, A.D., Chen, C.I., Sutton, D., Reece, D., Voralia, M., Stewart, A.K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
44
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/1042819031000067918
Date:
January, 2003
File:
PDF, 72 KB
english, 2003
Conversion to is in progress
Conversion to is failed